Conceptual visualization. Routes and points are symbolic and do not represent actual shipping lanes.
MIAMI brings four areas of work together so that a medicine's path, from the first commercial conversation to its destination, stays orderly, transparent and traceable.
Building cooperation pathways to source medicines, aligned with market needs and the applicable requirements.
Coordinating distribution with a focus on operational discipline, accuracy and responsiveness.
Building long-term commercial relationships on transparency, commitment and shared interest.
An integrated view of planning, documentation and follow-up along the entire route.
We hold a simple belief: a medicine only fulfils its purpose when its journey is handled with precision, responsibility and transparency. MIAMI exists for that journey.
We see the pharmaceutical supply chain as one continuous route, from understanding market needs and evaluating supply pathways to coordinating distribution and following up after delivery. Every link along it matters.
Respect for regulatory requirements and good distribution principles, accurate documentation and attention to each product's storage conditions form the basis of every partnership we enter.
Our goal is to build lasting partnerships that create real, dependable value for suppliers, distribution partners and, ultimately, patients.
MIAMI's services run along two independent yet aligned pathways, each focused on the distinct needs of commercial partners.
Creating cooperation pathways for pharmaceutical supply and developing commercial relationships, in line with market needs and the applicable requirements.
Providing distribution solutions and cooperation across the pharmaceutical supply chain, focused on operational discipline, responsiveness and commercial trust.
Select a stage to see what MIAMI focuses on at that link. This is a conceptual model of how we approach the work.
Understanding market needs and evaluating supply pathways before any commitment.
Conceptual visualization. Routes and points are symbolic and do not represent actual shipping lanes.
Search the catalogue by product name or filter it by category.
The items in this section are demonstration content that show how the catalogue works. Verified product information will replace them soon.
6 products
A sample listing for a solid oral dosage form in blister packs, showing how a product page is structured.
A sample capsule listing that outlines general storage considerations.
A sample listing for a sterile injectable and its general handling requirements.
A sample listing for a topical product in a tube, with general storage notes.
This section introduces MIAMI's business partners. Logos are displayed only after a partnership is confirmed and permission to use them has been granted.
Partner logos are shown here only after a partnership is confirmed and permission to use the logo has been granted.
The latest articles, insights and perspectives on the pharmaceutical industry and its supply chain.
Articles in this section are sample content. They are not official company news or announcements.
Some medicines, including many vaccines and biological products, stay stable only within a defined temperature range. Keeping that range intact from origin to destination is an inseparable part of medicine quality.
Good Distribution Practice (GDP) is a framework that helps keep the quality and integrity of medicines intact along the distribution route, just as they were when they left manufacturing.
Traceability makes it possible to follow each medicine pack from production to patient, and it is one of the most effective tools for protecting the integrity of the supply chain.
Get in touch to explore cooperation opportunities in pharmaceutical supply, import and distribution.
